On World Multiple Sclerosis Day be warned hat blurred vision and eye pain may be early signs of the undiagnosed neurological ...
Oculis Holding AG shares plunged >35% after both Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema failed primary ...
Australia’s access to affordable medicines could be under threat from global tensions, with one woman forced to fork out $220 ...
Key Points Interested in Oculis Holding AG? Here are five stocks we like better. Oculis' Phase 3 DIAMOND trials of OCS-01 in ...
4d
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema
The primary endpoint of mean change in best corrected visual acuity (BCVA) from baseline to week 52 in both Phase 3 trials was not met The ...
NRx Pharmaceuticals made significant operational progress by clearing key U.S. regulatory milestones for KETAFREE, advancing ...
Multiple Sclerosis can occur at any age, but most commonly affects young adults between 20 and 40 years of age ...
RALEIGH, NC, UNITED STATES, February 25, 2026 /EINPresswire.com/ — M2 Optics Inc., a leading global manufacturer of advanced packaged optical fiber solutions, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results